Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Related Posts
New Phase III Data of RSV Vaccine Arexvy Shows Efficacy Through Three Full Seasons
Image Credit: © Aerial Mike – stock.adobe.com GSK has shared positive Phase III data from its AReSVi-006 trial of Arexvy,…
Addressing Clinical Trial Challenges Through AI and Scalable Solutions
ACT: What advancements do you foresee for Medable AI and Medable Studio, and how might these innovations change the way…
Complexities with Managing the Overabundance of Clinical Technology
In a recent video interview with Applied Clinical Trials, Jeff Sidell, PhD, chief technology officer, Advarra, discussed current challenges in…
